Argenx
ARGX
#419
Rank
A$84.55 B
Marketcap
A$1,358
Share price
-1.62%
Change (1 day)
42.22%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report